Android app Apple app link

Revolution Medicines, Inc. (RVMD) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$37.39

south_east
-$0.05 (-0.13%)
Day's range
$37
Day's range
$37.62

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
04/01/2025 Stifel Nicolaus Benjamin Burnett $64.00 $33.62   90.36%
01/08/2025 UBS Eliana Merle $71.00 $44.33   60.16%
11/07/2024 Piper Sandler Joseph Catanzaro $70.00 $56.09   24.8%
11/04/2024 H.C. Wainwright Raghuram Selvaraju $62.00 $55.87   10.97%
10/28/2024 Guggenheim Michael Schmidt $82.00 $46.96   74.62%
10/28/2024 Oppenheimer Jay Olson $60.00 $46.83   28.12%
10/15/2024 Oppenheimer Jay Olson $55.00 $49.22   11.74%
09/17/2024 Piper Sandler Joseph Catanzaro $57.00 $44.24   28.84%
08/08/2024 Needham Ami Fadia $61.00 $42.73   42.76%
07/15/2024 Wedbush Robert Driscoll $59.00 $47.01   25.52%
04/19/2024 Stifel Nicolaus Ben Burnett $43.00 $35.83   20.01%
04/12/2024 Needham Ami Fadia $46.00 $37.41   22.96%
04/12/2024 Oppenheimer Jay Olson $45.00 $37.41   20.29%
04/09/2024 Raymond James Laura Prendergast $48.00 $32.99   45.5%
11/16/2023 Raymond James Dane Leone $30.00 $21.25   41.18%

Revolution Medicines, Inc. FAQ's

Revolution Medicines, Inc. has been rated by research analysts at Stifel Nicolaus, UBS, Piper Sandler, H.C. Wainwright, Guggenheim, Oppenheimer in the past 90 days.

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

To become a member, please download and purchase membership through our app.